https://www.fda.gov/drugs/news-events-human-drugs/fdacrcg-considerations-and-alternatives-comparative-clinical-endpoint-and-pharmacodynamic
FDA recommendations for establishing bioequivalence (BE) with local drug delivery for orally inhaled drug products (OIDPs) often involve study designs for...
clinical endpointfdaalternativescomparative